Study of the drug MK-1406 in healthy participants
This trial is testing a new drug, MK-1406, in healthy volunteers to see how the body processes it. It helps researchers find the right dose and check for side effects before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good general health.
- Your BMI should be between 18.0 and 32.0.
- You must not have any major health conditions affecting your body systems (like heart, liver, kidney, etc.).
- You must not have a history of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called MK-4082 in healthy people to see how safe it is and how the body handles it. It may help understand if the drug could be used for future treatments.
This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.
This trial tests an investigational drug called MK-6916 in healthy volunteers to see how it interacts with two common medicines (midazolam and rosuvastatin). It helps understand how the body processes these drugs together.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This study tests a new oral medication for psoriasis in healthy volunteers to check its safety and how the body handles it. It is an early-phase trial to gather information before testing in patients.
This study tests how a new drug (BMS-986435) is absorbed by the body and whether food changes that. It is for healthy volunteers to help understand the right dose for future patients.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.